Trending Keywords

Christine Blasey Ford
Emmy Awards
Rite Aid
President Donald Trump
Sesame Street
Aberdeen Maryland
Judge Brett Kavanaugh
Senate Judiciary Committee
Harford County Maryland
North Korea
American Red Cross
Puerto Rico
Wilmington North Carolina
Hurricane Florence
Super Bowl
Hurricane Maria
New Bern
President Trump
Typhoon Mangkhut
Attorney General Jeff Sessions
United Way
Yusaku Maezawa
Ohio State
Colin Kaepernick
Space Jam
Playstation Classic
Federal Emergency Management Agency
Tropical Storm Florence
South Korean President Moon
Pope Francis
Green Bay
Celia Barquin Arozamena
Stormy Daniels
Ariana Grande
Catholic Church
Notre Dame
Mark Cuban
Hillary Clinton
South Africa
Mac Miller
Robert Mueller
Public Safety
Paul Manafort
West Nile Virus
Tampa Bay
Labor Day
Lebron James
Disease Control
Wilmington NC
Red Sox
High School Football
Democratic Party
Human Services
Philadelphia Eagles
Apple Watch
Tropical Depression Florence
Social Security
Anita Hill
Public Health
Homeland Security
European Union
National Hurricane Center
Big Ten
Election Day
National Cheeseburger Day
New England Patriots
Silicon Valley
Saudi Arabia
Drug Administration
Star Wars
Penn State
Border Patrol
Les Moonves
Beto O'Rourke
Iowa State
Cleveland Browns
Marvelous Mrs Maisel
Glenn Weiss
Texas A&M
Constitution Day
Josh Gordon
Julie Chen
Saturday Night Live
Myrtle Beach
Dallas Cowboys
Kanye West
State Mike Pompeo
Tiger Woods
Michigan State
Salvation Army
America's Got Talent
Paul McCartney
Captain Marvel
Black Panther
Columbia Gas
Mary Poppins Returns
Aaron Rodgers
Florida State
New York Fashion
Montgomery County
More Hot Topics
Show me NEWS 'bout


This gene therapy for vision loss will initially cost $850,000... [Read More]
The gene therapy, used to treat an inherited form of blindness, is now the most expensive medicine in the US. [Read More]
AP A gene therapy to treat an inherited form of blindness is now the most expensive medicine in the US. The one-time treatment... [Read More]
The historic treatment's costs could top $1 million... [Read More]
Alnylam Pharmaceuticals announced positive results Wednesday from a closely watched phase 3 clinical trial of patisiran. [Read More]
Thomson Reuters The age of RNA interference drugs has arrived. Alnylam Pharmaceuticals announced positive results Wednesday from a closely watched phase 3 clinical trial... [Read More]
Associated Press/Andrew Harnik One of the few treatments shown to prolong the lives of patients with brain tumors like Sen. John McCain's is... [Read More]
Vertex Pharmaceuticals scored a win with the release of data from three clinical trials testing three different triple combinations of cystic fibrosis drugs. [Read More]
AP Vertex Pharmaceuticals scored a major win Tuesday with the release of data from three clinical trials testing three different triple combinations of... [Read More]
After 16 years writing about biotech stocks for TheStreet, it's time for this writer to say goodbye and thank you. [Read More]
Hope spring eternal, until it's dashed on the rocks and buried at sea....CYTR... [Read More]
Rivals Kite Pharma and Novartis are still out in front, but updated efficacy and safety data from Juno's JCAR017 program in patients with aggressive non-Hodgkin's... [Read More]
100% response rate with zero relapses are the latest update from Bluebird's BB2121 study in multiple myeloma patients....BLUE... [Read More]
This will be the investors' verdict on the results of Roche's APHINITY study of Perjeta in adjuvant breast cancer treatment that were released Monday morning....RHHBY... [Read More]
Incyte's actions are another reminder that biotech companies carefully groom and manage the clinical data they want investors to see, even at important, open medical... [Read More]
Incyte and Merck are combining two cancer immunotherapy drugs to treat patients with non-small cell lung cancer....INCY... [Read More]
The Loxo data also represent another advance for precision cancer medicine, in which patients are treated with drugs that target specific tumor mutations, regardless of... [Read More]
A head-to-head showdown in metastatic breast cancer and the Roche APHINITY data are next key events for Puma....PBYI... [Read More]
An FDA advisory panel is reviewing Puma's breast cancer drug neratinib. [Read More]
The lack of "OMG" bombshells in the FDA's neratinib review are a Monday win for Puma bulls, and the stock is soaring....PBYI... [Read More]
Jump To:
Aaron Rodgers - Aberdeen Maryland - America's Got Talent - American Red Cross - Anita Hill - Apple Watch - Ariana Grande - Attorney General Jeff Sessions - Beto O'Rourke - Big Ten - Black Panther - Border Patrol - Captain Marvel - Catholic Church - Celia Barquin Arozamena - Christine Blasey Ford - Cleveland Browns - Colin Kaepernick - Columbia Gas - Constitution Day - Dallas Cowboys - Democratic Party - Disease Control - Drug Administration - Election Day - Emmy Awards - European Union - Federal Emergency Management Agency - Florida State - Glenn Weiss - Green Bay - Harford County Maryland - High School Football - Hillary Clinton - Homeland Security - Human Services - Hurricane Florence - Hurricane Maria - Iowa State - Josh Gordon - Judge Brett Kavanaugh - Julie Chen - Kanye West - Labor Day - Lebron James - Les Moonves - Mac Miller - Mark Cuban - Marvelous Mrs Maisel - Mary Poppins Returns - Michigan State - Montgomery County - Myrtle Beach - National Cheeseburger Day - National Hurricane Center - New Bern - New England Patriots - New York Fashion - North Korea - Notre Dame - Ohio State - Paul Manafort - Paul McCartney - Penn State - Philadelphia Eagles - Playstation Classic - Pope Francis - President Donald Trump - President Trump - Public Health - Public Safety - Puerto Rico - Red Sox - Rite Aid - Robert Mueller - Salvation Army - Saturday Night Live - Saudi Arabia - Senate Judiciary Committee - Sesame Street - Silicon Valley - Social Security - South Africa - South Korean President Moon - Space Jam - Star Wars - State Mike Pompeo - Stormy Daniels - Super Bowl - Tampa Bay - Texas A&M - Tiger Woods - Tropical Depression Florence - Tropical Storm Florence - Typhoon Mangkhut - United Way - West Nile Virus - Wilmington NC - Wilmington North Carolina - Yusaku Maezawa